I n a world where seeking help to manage weight is still frowned upon and deemed as “lazy,” many are turning to common tools ...

Medifast, Inc. faces declining demand amid GLP-1 impact, struggling repositioning efforts, and earnings uncertainty. Read ...

Pharma giant Novo Nordisk, which makes the obesity drug Wegovy, says the widespread availability of copycat medications is hurting its sales.

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your body to burn more fat instead and hang on to muscle. There’s also a ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-2 diabetes- and it may not be safe.

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Pharma giant Novo Nordisk, which makes the obesity drug Wegovy, says the widespread availability of copycat medications is hurting its sales.

Gallagher Re, a reinsurance brokerage and risk management services provider, has released a report on the impact of GLP-1 ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

The Weill Cancer Hub East has been established to explore the “interplay” between nutrition and immunotherapy in cancer ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...